FdaApplication
ANDA 212367
Identifiers
- fda_app_no: ANDA212367
Properties
| Property | Value |
|---|---|
| applicant_name | PADAGIS ISRAEL PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2020-09-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE | 0.064%;0.005% | SUSPENSION;TOPICAL |
1 product